“Adoption of Minimally and Non-Invasive Monitoring Technologies”
- A significant and accelerating trend in the global hemodynamic monitoring market is the growing shift toward minimally invasive and non-invasive technologies, driven by the demand for safer, faster, and more patient-friendly diagnostic procedures in critical care and perioperative settings
- For instance, Edwards Lifesciences’ ClearSight system allows continuous non-invasive blood pressure and cardiac output monitoring, offering real-time hemodynamic insights without the need for catheterization. Similarly, CNSystems' CNAP Monitor provides beat-to-beat blood pressure measurement using a finger cuff, enhancing patient safety during surgeries
- These advanced systems reduce the risk of complications associated with invasive procedures, shorten recovery times, and are easier to deploy in a broader range of clinical settings, including outpatient and ambulatory care
- Integration with digital platforms and electronic health records (EHRs) further enables continuous data recording and remote monitoring capabilities, making it easier for clinicians to track trends and make informed decisions
- This trend is reshaping expectations for patient monitoring, prompting medical device manufacturers to focus on compact, wireless, and AI-enhanced solutions that improve clinical workflow efficiency. For example, Biobeat offers wearable hemodynamic monitors with wireless data transmission for use in both hospital and home-care environments
- As healthcare systems worldwide move toward value-based and patient-centric care, the demand for reliable, non-invasive hemodynamic monitoring is rapidly growing, offering clinicians greater flexibility and improving outcomes in critical care, cardiology, and surgery
